Latest Articles

Publication Date
Regarding "A Multicenter Study Assessing the Diagnostic Accuracy of Ultrasonographic Features of the Uterosacral Ligaments in Patients with and without Endometriosis".

Published: Nov. 29, 2025, midnight
Mesothelin as a Diagnostic Biomarker in Endometriosis: A Cross-Sectional Study.

Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal …

Published: Nov. 28, 2025, midnight
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - The Progress Index

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis The Progress Index

Published: Nov. 26, 2025, 4:31 a.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Montgomery Advertiser

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Montgomery Advertiser

Published: Nov. 26, 2025, 1:16 a.m.
May serum advanced oxidation protein products levels be diagnostic markers in endometrioma?

To evaluate the diagnostic utility of advanced oxidation protein products (AOPPs), calprotectin, and classical tumor markers (CA 125 and CA19-9) in distinguishing ovarian endometriomas from simple cysts and healthy controls, …

Published: Nov. 26, 2025, midnight
Urine and Serum miRNA Signatures for the Non-Invasive Diagnosis of Adenomyosis: A Machine Learning-Based Pilot Study.

Background: Adenomyosis remains difficult to diagnose non-invasively due to clinical overlap with endometriosis and the limited specificity of imaging techniques. This pilot study evaluated whether serum- and urine-derived microRNA (miRNA) …

Published: Nov. 26, 2025, midnight
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Beaver County Times

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Beaver County Times

Published: Nov. 25, 2025, 9:18 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Central New Jersey News

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Central New Jersey News

Published: Nov. 25, 2025, 8:33 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - The Herald-Mail

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis The Herald-Mail

Published: Nov. 25, 2025, 6:12 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Akron Beacon Journal

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Akron Beacon Journal

Published: Nov. 25, 2025, 5:16 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!